Sarah Ladd Dennewitz, MS, MFT | |
4705 Old Post Rd Unit A, Charlestown, RI 02813-1842 | |
(401) 364-7705 | |
(401) 364-3310 |
Full Name | Sarah Ladd Dennewitz |
---|---|
Gender | Female |
Speciality | Marriage & Family Therapist |
Location | 4705 Old Post Rd Unit A, Charlestown, Rhode Island |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1922256544 | NPI | - | NPPES |
1922256544-SD84360 | Medicaid | RI | |
1922256544 | Other | RI | UNITED HEALTHCARE |
497007 | Other | RI | TRICARE |
497007 | Other | RI | MHN |
GH57134 | Medicaid | RI | |
1922256544 | Other | RI | BCBSRI |
3827866 | Other | RI | CIGNA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
106H00000X | Marriage & Family Therapist | MFT00138 (Rhode Island) | Primary |
Mailing Address | Practice Location Address |
---|---|
Sarah Ladd Dennewitz, MS, MFT Po Box 899, Charlestown, RI 02813-0899 Ph: (401) 364-7705 | Sarah Ladd Dennewitz, MS, MFT 4705 Old Post Rd Unit A, Charlestown, RI 02813-1842 Ph: (401) 364-7705 |
News Archive
WellStar Health System was the first to implement and is the only health system in metro-Atlanta using Xenex Healthcare Services' room disinfection system in its patient and operating rooms. A "green," mercury-free technology, the Xenex system is the fastest, safest and most effective method for the advanced cleaning of hospital rooms, scientifically proven to destroy all major classes of microorganisms that cause hospital acquired infections (HAIs), such as MRSA and Clostridium difficile (C. diff).
AbbVie, a global biopharmaceutical company, today announced that 91 percent (n=20/22) of genotype 1 (GT1) chronic hepatitis C virus (HCV) infected patients who failed previous therapy with direct-acting antivirals (DAAs) achieved SVR12 with 12 weeks of ABT-493 and ABT-530 with ribavirin (RBV) in the primary intent-to-treat analysis.
Physicians at Rush University Medical Center are offering a new and effective treatment to patients suffering from complex brain aneurysms. The recently FDA-approved technology called the Pipeline Embolization Device (PED) gives doctors the ability for the very first time to treat some of the most complex and dangerous brain aneurysms using minimally invasive techniques.
LifeSpan BioSciences, Inc., a leading provider of antibodies for thousands of researchers worldwide, has increased the number of validated IHC-plus™ antibodies available in its catalog to more than 3,500. With this increase, LifeSpan is well on its way to building the world's largest catalog of well characterized, IHC-validated reagent antibodies. Overall, LifeSpan has a catalog of more than 82,000 antibodies.
It is commonly believed that we have a poor sense of smell relative to other mammals, most notably the dog. However, a review published today reports that, based on 14 years of study of the olfactory system, humans have an excellent ability to discern different odours. We are just sensitive to different scents compared with other mammals.
› Verified 7 days ago
Jennifer Baerlocher, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 4705 Old Post Rd Unit A, Charlestown, RI 02813 Phone: 401-364-7705 Fax: 401-364-7705 | |
Hope Thulier, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 100 Alder Rd, Charlestown, RI 02813 Phone: 401-284-6837 |